| 51 |
20231858 | Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians. | 2011 Apr |
3 |
| 52 |
21219398 | 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. | 2011 Feb |
2 |
| 53 |
21507593 | A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4β-hydroxycholesterol in human plasma. | 2011 Jul 15 |
1 |
| 54 |
21728364 | Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis. | 2011 Sep 19 |
2 |
| 55 |
20197489 | Does the long plasma half-life of 4beta-hydroxycholesterol impact its utility as a cytochrome P450 3A (CYP3A) metric? | 2010 Nov |
8 |
| 56 |
19006545 | 4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin. | 2009 Jan |
4 |
| 57 |
19458613 | Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric? | 2009 Aug |
1 |
| 58 |
19954708 | 4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man. | 2009 Dec |
4 |
| 59 |
18279471 | Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy. | 2008 May |
3 |
| 60 |
18300941 | 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians. | 2008 Mar |
4 |
| 61 |
18458892 | CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels. | 2008 Aug |
3 |
| 62 |
16847425 | Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin. | 2006 Aug |
1 |
| 63 |
11514559 | Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. | 2001 Oct 19 |
2 |